Media enquiries

Solving Kids' Cancer is more than happy to offer information about neuroblastoma to journalists.

We can also liaise with the families we support if you are interested in publishing a story about a particular child or their campaign.

Media contact

Solving Kids' Cancer office
0207 284 8000

Latest

MY BIRTHDAY GIFT TO LIAM

To support my precious Grandson Liam get to the US for his life saving vaccine in Sept. He is my hero and Little Warrior and always will be. He has been through so much this last year and I am in awe of how he has handled it so well...a real little fighter. Love you lots and lots Ganny Jenny😍😍😍
Important Update - Shielding Guidelines

Important Update - Shielding Guidelines The Government have confirmed revised amendments to the shielding guidelines for children and young people [0-18 years].
Solving Kid's Cancer
Nellie-Rose's Campaign

Nellie-Rose is battling a disease no child should have to. She has high-risk neuroblastoma, an aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis.

Most read

Lily-Mae, Ireland’s Tiny Dancer, supports Solving Kids’ Cancer

Lily-Mae from Galway, Ireland will be celebrating her 12th birthday this April, but for her parents Judith and Leighton every day is a blessing.
Corey is thriving after neuroblastoma battle

Family donate almost £150,000 to neuroblastoma research
BEACON study opens in Europe

The much-anticipated BEACON study amendment is now open and recruiting patients.
Steve Richards to step down as Chief Executive

CEO to leave Solving Kids' Cancer after three years in the role.
Liam's Appeal

Liam has high-risk neuroblastoma and his family are appealing for your help to raise £232,000 by August 2020.
Solving Kids’ Cancer appoints new Chief Executive Officer

Solving Kids’ Cancer, a national neuroblastoma charity, has appointed Gail Jackson as its new Chief Executive Officer.
Charities fund new clinical trial

Solving Kids’ Cancer, with Neuroblastoma UK, has awarded a grant of £609,762.40 to enable the SIOPEN High-Risk Neuroblastoma Clinical Trial 2 (HR-NBL2) to open in the UK, it is anticipated to open in early 2021.
Ewen's Urgent Appeal

Ewen is a happy and restless boy who runs everywhere. He loves trucks, cars and blowing dandelions. But this amazing little boy has had his childhood interrupted by childhood cancer.
Nellie-Rose's Campaign

Nellie-Rose is battling a disease no child should have to. She has high-risk neuroblastoma, an aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis.
Henry's Appeal

Henry has high-risk neuroblastoma, an aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis. His family are appealing for your help to raise £202,000 by January 2021.